GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (FRA:818) » Definitions » ROE % Adjusted to Book Value

Zylox-Tonbridge Medical Technology Co (FRA:818) ROE % Adjusted to Book Value : 4.86% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zylox-Tonbridge Medical Technology Co ROE % Adjusted to Book Value?

Zylox-Tonbridge Medical Technology Co's ROE % for the quarter that ended in Jun. 2024 was 4.47%. Zylox-Tonbridge Medical Technology Co's PB Ratio for the quarter that ended in Jun. 2024 was 0.92. Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 4.86%.

Zylox-Tonbridge Medical Technology Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zylox-Tonbridge Medical Technology Co ROE % Adjusted to Book Value Chart

Zylox-Tonbridge Medical Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - -5.81 -3.09 -2.21 3.24

Zylox-Tonbridge Medical Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -4.78 -1.85 -2.49 4.86 2.01

Competitive Comparison of Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value falls into.


;
;

Zylox-Tonbridge Medical Technology Co ROE % Adjusted to Book Value Calculation

Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-2.50% / 1.13
=-2.21%

Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=4.47% / 0.92
=4.86%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zylox-Tonbridge Medical Technology Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zylox-Tonbridge Medical Technology Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Zylox-Tonbridge Medical Technology Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zylox-Tonbridge Medical Technology Co Ltd (FRA:818) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:01858 HKSE:02291 HKSE:01763 HKSE:01789 HKSE:02172 HKSE:09996 HKSE:01302 HKSE:02235 HKSE:06669 HKSE:02160 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
02190:Hong Kong 818:Germany
Address
270 Shuyun Road, Cangqian Street, Zylox-Tonbridge Industrial Park, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.zyloxtb.com
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB).

Zylox-Tonbridge Medical Technology Co Headlines

No Headlines